These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1498373)

  • 1. Telogen effluvium due to recombinant interferon alpha-2b.
    Tosti A; Misciali C; Bardazzi F; Fanti PA; Varotti C
    Dermatology; 1992; 184(2):124-5. PubMed ID: 1498373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
    Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
    Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of etretinate alopecia.
    Berth-Jones J; Shuttleworth D; Hutchinson PE
    Br J Dermatol; 1990 Jun; 122(6):751-5. PubMed ID: 2369555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telogen effluvium after allergic contact dermatitis of the scalp.
    Tosti A; Piraccini BM; van Neste DJ
    Arch Dermatol; 2001 Feb; 137(2):187-90. PubMed ID: 11176691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced hair loss and hair growth. Incidence, management and avoidance.
    Tosi A; Misciali C; Piraccini BM; Peluso AM; Bardazzi F
    Drug Saf; 1994 Apr; 10(4):310-7. PubMed ID: 8018303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs and hair loss.
    Patel M; Harrison S; Sinclair R
    Dermatol Clin; 2013 Jan; 31(1):67-73. PubMed ID: 23159177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telogen Effluvium: A Review of the Literature.
    Asghar F; Shamim N; Farooque U; Sheikh H; Aqeel R
    Cureus; 2020 May; 12(5):e8320. PubMed ID: 32607303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic telogen effluvium: a study of 5 patients over 7 years.
    Sinclair R
    J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):12-6. PubMed ID: 15692504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute telogen effluvium triad after resolution.
    Contin LA; Rocha VB
    An Bras Dermatol; 2021; 96(5):605-608. PubMed ID: 34272075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permanent alopecia after systemic chemotherapy: a clinicopathological study of 10 cases.
    Miteva M; Misciali C; Fanti PA; Vincenzi C; Romanelli P; Tosti A
    Am J Dermatopathol; 2011 Jun; 33(4):345-50. PubMed ID: 21430504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral zinc therapy for zinc deficiency-related telogen effluvium.
    Karashima T; Tsuruta D; Hamada T; Ono F; Ishii N; Abe T; Ohyama B; Nakama T; Dainichi T; Hashimoto T
    Dermatol Ther; 2012; 25(2):210-3. PubMed ID: 22741940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic telogen effluvium.
    Whiting DA
    Dermatol Clin; 1996 Oct; 14(4):723-31. PubMed ID: 9238330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 infection is a major cause of acute telogen effluvium.
    Sharquie KE; Jabbar RI
    Ir J Med Sci; 2022 Aug; 191(4):1677-1681. PubMed ID: 34467470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort study.
    Kanti V; Nuwayhid R; Lindner J; Hillmann K; Stroux A; Bangemann N; Kleine-Tebbe A; Blume-Peytavi U; Garcia Bartels N
    Br J Dermatol; 2014 Mar; 170(3):643-50. PubMed ID: 24641211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional methods for diagnosing alopecia and appraising their severity.
    Guarrera M
    G Ital Dermatol Venereol; 2014 Feb; 149(1):93-102. PubMed ID: 24566569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of QR678 Neo
    Shome D; Kapoor R; Surana M; Vadera S; Shah R
    J Cosmet Dermatol; 2022 Jan; 21(1):16-23. PubMed ID: 34875139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proprietary herbal extract against hair loss in androgenetic alopecia and telogen effluvium: a placebo-controlled, single-blind, clinical-instrumental study.
    Pekmezci E; Dündar C; Türkoğlu M
    Acta Dermatovenerol Alp Pannonica Adriat; 2018 Jun; 27(2):51-57. PubMed ID: 29945259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic telogen effluvium is due to a reduction in the variance of anagen duration.
    Gilmore S; Sinclair R
    Australas J Dermatol; 2010 Aug; 51(3):163-7. PubMed ID: 20695853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anagen effluvium secondary to
    Bains A; Verma GK; Vedant D; Negi A
    Indian J Dermatol Venereol Leprol; 2016; 82(6):677-680. PubMed ID: 27451928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teloptosis, a turning point in hair shedding biorhythms.
    Piérard-Franchimont C; Piérard GE
    Dermatology; 2001; 203(2):115-7. PubMed ID: 11586007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.